Acid suppression in a critical care environment: State of the art and beyond

Critical Care Medicine

Volumn 30, Issue 6 SUPPL., 2002, Pages

  Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Acid suppression; Clinically important bleeding; Critically ill patients; Gastrointestinal hemorrhage; Histamine 2 receptor antagonists; Intensive care unit; Intravenous; Prophylaxis; Proton pump inhibitors; Stress ulceration

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PANTOPRAZOLE; PROTON PUMP INHIBITOR; SUCRALFATE;

ASPIRATION PNEUMONIA; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; DUODENUM ULCER; EDITORIAL; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; INTENSIVE CARE; INTESTINE BLOOD FLOW; INTESTINE MUCOSA; PANCREATITIS; PRIORITY JOURNAL; STOMACH ULCER; STRESS ULCER; TREATMENT PLANNING; ZOLLINGER ELLISON SYNDROME;

EID: 0036273493     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200206001-00001     Document Type: Editorial

References (9)

1. Risk factors for gastrointestinal bleeding in critically ill patients: Canadian Critical Care Trials Groups
2. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation: Canadian Critical Care Trials Group
3. Do continuous omeprazole and ranitidine retain their effect with prolonged dosing
4. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome
5. Cimetidine and tranexamic acid in the treatment of acute upper gastrointestinal-tract bleeding
6. Continuous intravenous famotidine for haemorrhage from peptic ulcer
7. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy
8. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers